PDF factsheet

antiplatelets drug in acute coronary syndrome for patients not initialy planned for PCI, clinical trials results

prasugrel versus clopidogrel
TRILOGY ACS (overall population), 2012
prasugrel 10 mg daily
clopidogrel 75 mg daily
patients with acute coronary syndromes selected for a final treatment strategy of medical management without revascularization within 10 days after the index eventdouble-blind
Follow-up duration: 17 months (median)
52 countries


in first

in second